Home
Directory
MapJobsInsightsNewsLearn More
Claim Your Page

A discovery platform for biotech and life sciences, built to improve visibility, discovery, and connection across the ecosystem.

Follow Us

Explore

  • Directory
  • Categories
  • Map
  • Jobs
  • Insights
  • News
  • Learn More
  • Claim Your Page
  • Help & Support

Grow with Benchscope

  • Upgrade to Premium
  • Post a Job
  • Sponsor a Focus Area
  • Data Licensing
  • Press Enquiries

© 2026 Benchscope Ltd. All rights reserved.

Benchscope Ltd is registered in England and Wales. Company number: 16664850. Registered office: 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.

Privacy PolicyTerms of ServiceCookie Policy
Directory

Wound Care Companies in the UK

Wound care companies develop products and technologies that support the treatment, protection and healing of acute and chronic wounds. Their work spans infection control, tissue repair, wound monitoring and the management of complex conditions such as diabetic ulcers and pressure injuries.

This category includes companies working on:

  • Advanced wound dressings and biomaterials
  • Antimicrobial and infection-control products
  • Chronic wound and diabetic ulcer management
  • Tissue repair and regenerative technologies
  • Wound monitoring, diagnostics and healing assessment

Browse 22 UK wound care companies below.

View full directory
Wound Care
Showing 21–22 of 22
Sort by

Jellagen

CardiffWales

Jellyfish-derived collagen biomaterials for research and regenerative medicine

Jellagen is a Welsh biotechnology company developing and manufacturing collagen biomaterials derived from sustainably harvested jellyfish. Its proprietary Collagen Type 0 is compatible with a broad range of human cell types, making it suitable for cell culture, tissue engineering, wound care, and regenerative medicine…

Reagents & ConsumablesBiomaterials
View profile

LightOx

NewcastleNorth East England

Light-activated small molecule therapies for oral cancer and wound care

LightOx is a biotechnology company developing light-activated small molecule therapeutics for cancer and infection. Its lead candidate LXD191 is a topically applied photosensitising compound targeting early-stage oral cancer and pre-cancerous lesions, activated by a specific wavelength of light to generate reactive…

BiopharmaDrug Discovery
View profile
Prev
12
12

Benchscope

Sponsored

Sponsor your focus area

Reach buyers and partners across relevant directory pages and company profiles.

Premium Profiles

Upgrade your visibility on Benchscope

Promote your company with a premium or featured profile and stand out to biotech buyers, partners, and decision-makers exploring the directory.

Explore Premium